Table 5.
Distribution of Clones According to the Seroreactivity Frequency Determined for Glioma and for Healthy Controls (First and Second Column).
Frequency Range | Glioma | Healthy | Glioma (Twice) | |||
No. All Clones | No. In-frame Clones | No. All Clones | No. In-frame Clones | No. All Clones | No. In-frame Clones | |
0% | 51 | 17 | 176 | 62 | — | — |
0–10% | 536 | 176 | 552 | 169 | 152 | 91 |
10–20% | 444 | 117 | 305 | 78 | 109 | 49 |
20–30% | 187 | 40 | 163 | 36 | 34 | 5 |
30–40% | 100 | 20 | 93 | 22 | 7 | 2 |
40–50% | 54 | 14 | 55 | 8 | 3 | 0 |
50–60% | 22 | 3 | 30 | 9 | 2 | 0 |
60–70% | 16 | 4 | 27 | 5 | 1 | 0 |
70–80% | 4 | 0 | 11 | 2 | 0 | 0 |
80–90% | 3 | 0 | 4 | 0 | 0 | 0 |
90–100% | 0 | 0 | 1 | 0 | 0 | 0 |
The third column lists clones that react at least twice as often with glioma sera than with healthy control sera. Number of all clones and number of in-frame clones are given for each frequency interval.